FineTest ELISA kit contributes to the research on prevention of osteoarthritis progression. The immunoassay is designed to measure GAGs level in chondrocytes.
Article Title: UGDH Lactylation Aggravates Osteoarthritis by Suppressing Glycosaminoglycan Synthesis and Orchestrating Nucleocytoplasmic Transport to Activate MAPK Signaling
Journal Title: Advanced Science
DOI: 10.1002/advs.202413709
IF: 14.3
PMID: 40150862
Abstract: Osteoarthritis (OA) progression is closely related to dysregulated glycolysis. As the primary metabolite of glycolysis, lactate plays a detrimental role in OA. However, how lactate exacerbates OA process remains unclear. Here, this study revealed that lactate levels are elevated in the synovial fluid of OA patients and IL-1β-treated human primary chondrocytes, promoting protein pan-lactylation. Functionally, hyper-lactylation exacerbates chondrocytes extracellular matrix (ECM) degradation and cell apoptosis in vitro and in vivo. Moreover, UDP-glucose dehydrogenase (UGDH) is proven to be the key lactylated protein in lactate-treated chondrocytes, which undergoes lactylation at lysine 6 (K6). Lactylated UGDH repressed its enzymatic activity, reducing glycosaminoglycan synthesis and disregulating its nuclear-cytoplasmic distribution. Mechanistically, K6 lactylation of UGDH impedes the interaction of UGDH and signal transducer and activator of transcription 1 (STAT1), thus promoting the transcription of mitogen-activated protein kinase kinase kinase 8 (MAP3K8) and activating the MAPK signaling pathway. Importantly, in vitro and in vivo treatment with A485, a specific acyltransferase P300 inhibitor, suppressed UGDH lactylation and rescued chondrocytes ECM degradation and OA progression. These findings uncover a new mechanism underlying OA pathogenesis and highlight the potential of targeting UGDH lactylation as a novel therapeutic strategy for OA.
Keywords: chondrocytes, lactate, lactylation, osteoarthritis progression, udp-glucose dehydrogenase
Immunoassay
FineTest Product | Sample | Species | Detection Target |
Human GAGs(Glycosaminoglycan) ELISA Kit(EH4235) | chondrocytes | Human | GAGs |
Validated Image
Figure Source: Adv Sci (Weinh). 2025 Mar 27:e2413709. doi: 10.1002/advs.202413709.